Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Price to Sales (2010 - 2026)

Geron's (GERN) quarterly Price to Sales came in at 14.31 in Q2 2026, down 22.01% year-over-year from 18.35 in Q2 2025, and down 22.21% quarter-over-quarter from 18.39 in Q1 2026.

Analysis

Geron (GERN) Price to Sales (2010 - 2026) Analysis & Trends

Geron has disclosed Price to Sales across 17 years of filings, most recently posting 14.31 for Q2 2026.

  • In Q2 2026, Price to Sales fell 22.01% year-over-year to 14.31; the TTM figure through Jun 2026 stood at 3.37 (down 33.68% YoY), while the FY2025 annual figure was 3.79, down 84.23% from the prior year.
  • Price to Sales came in at 14.31 for Q2 2026 at Geron, down from 18.39 in the prior quarter.
  • In the past five years, Price to Sales ranged from a high of 57931.72 in Q2 2023 to a low of 9.68 in Q4 2025.
  • Average Price to Sales over 5 years is 11192.04, with a median of 2950.73 recorded in 2022.
  • Year-over-year, Price to Sales jumped 2314.48% in 2022 and plunged 99.93% in 2024.
  • Over 5 years, Price to Sales stood at 9169.28 in 2022, then soared by 445.19% to 49989.77 in 2023, then tumbled by 99.93% to 35.8 in 2024, then sank by 72.96% to 9.68 in 2025, then soared by 47.79% to 14.31 in 2026.
  • Per Business Quant data, the three most recent Price to Sales figures were 14.31 in Q2 2026, 18.39 in Q1 2026, and 9.68 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Geron 914.60 Mn 613.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.31
Mar 31, 2026 18.39
Dec 31, 2025 9.68
Sep 30, 2025 18.52
Jun 30, 2025 18.35
Mar 31, 2025 25.57
Dec 31, 2024 35.80
Sep 30, 2024 97.08
Jun 30, 2024 2,897.79
Mar 31, 2024 6,438.61
Dec 31, 2023 49,989.77
Sep 30, 2023 7,020.09
Jun 30, 2023 57,931.72
Mar 31, 2023 52,572.58
Dec 31, 2022 9,169.28
Sep 30, 2022 3,003.67
Jun 30, 2022 8,022.18
Mar 31, 2022 4,173.40
Dec 31, 2021 379.76
Sep 30, 2021 4,046.52